![](https://scx1.b-cdn.net/csz/news/tmb/2016/tasquinimodi.jpg)
Tasquinimod improves radiographic PFS in mCRPC
(HealthDay)—For chemotherapy-naive men with metastatic castration-resistant prostate cancer (mCRPC), tasquinimod is associated with improved radiographic progression-free survival (rPFS), according to a phase III study ...
Jun 16, 2016
0
0